Daniel J. DeAngelo, MD, PhD

Daniel J. DeAngelo, MD, PhD, is a professor of medicine at Harvard Medical School and the chief of the Division of Leukemia at the Dana-Farber Cancer Institute in Boston, MA. Dr DeAngelo earned his MD and PhD in molecular genetics from Albert Einstein College of Medicine of Yeshiva University in Bronx, NY. He completed his internship and residency at Massachusetts General Hospital in Boston and clinical fellowships in medical oncology and hematology at the Dana-Farber Cancer Institute and the Brigham and Women’s Hospital, both in Boston. 

Dr DeAngelo’s clinical research focuses on optimizing therapy for adult leukemias, myelodysplastic syndromes, and myeloproliferative disorders, including systemic mast cell disorders. He is the co-chair emeritus of the National Cancer Institute. He also serves on the Leukemia Core Committee for the Alliance Cooperative Group and is principal investigator and coinvestigator for several ongoing clinical protocols. He also has an interest in the treatment of young adults with leukemia, particularly acute lymphoblastic leukemia and systemic mastocytosis.

Dr DeAngelo has authored or coauthored more than 200 original peer-reviewed manuscripts, review articles, and book chapters, and he has presented his work nationally and internationally.